U.S. Markets open in 6 hrs 17 mins

Baxter Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Baxter International, Inc. To Contact The Firm

Newsfile Corp.

New York, New York--(Newsfile Corp. - January 16, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Baxter International, Inc. (NYSE: BAX) ("Baxter" or the "Company") of the January 24, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.



Faruqi & Faruqi Logo

If you invested in Baxter stock or options between February 21, 2019 and October 23, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/BAX. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of all those who purchased Baxter securities between February 21, 2019 and October 23, 2019 (the "Class Period"). The case, Silverman v. Baxter International Inc. et al, No. 19-cv-07786 was filed on November 25, 2019, and has been assigned to Honorable Sara L. Ellis.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by misrepresenting and/or failing to disclose that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) the Company lacked effective internal control over financial reporting; (3) as a result, the Company's financial statements were misstated and would likely require correction or amendment; (4) due to the Company's internal investigation, Baxter would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on Form 10-Q in a timely manner; and (5) as a result of the foregoing, Defendants' statements about the Company's business and operations lacked a reasonable basis.

Specifically, before the markets opened on October 24, 2019, Baxter announced that it "recently began an investigation into certain intra-Company transactions undertaken for the purpose of generating foreign exchange gains or losses." According to the Company, "[t]hese transactions used a foreign exchange rate convention historically applied by the Company that was not in accordance with generally accepted accounting principles [("GAAP")] and enabled intra Company transactions to be undertaken after the related exchange rates were already known."

Baxter further admitted that "[t]hese intra-Company transactions resulted in certain misstatements in the Company's previously reported non-operating income related to net foreign exchange gains" and acknowledged that, "[u]pon completion of the investigation and the Company's evaluation of the materiality of the misstatements, the Company expects to either amend its periodic reports previously filed with the SEC to include restated financial statements that correct those misstatements, or include in reports for future periods restated comparative financial statements that correct those misstatements." As noted in the announcement, "the Company previously reported net foreign exchange gains of $8 million, $113 million, $28 million, $50 million, $73 million, and $22 million, for the years 2014, 2015, 2016, 2017, 2018, and the first half of 2019, respectively."

The Company further explained that "[t]he Audit Committee of the Company's Board of Directors is overseeing this investigation with the assistance of independent, experienced external advisors," that "Baxter voluntarily advised the staff of the [SEC] that the internal investigation is underway and intends to provide additional information to the SEC as the investigation progresses," and that "[t]he Company does not expect to file its quarterly report on Form 10-Q for the period ended September 30, 2019 on a timely basis."

On this news, Baxter's stock price fell from $87.95 on October 23, 2019 to a closing price of $79.08 on October 24, 2019-a $8.87 or 10.09% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Baxter's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/51536

  • Tesla will mark the beginning of the end for this bull market, warns Ralph Nader
    Business
    MarketWatch

    Tesla will mark the beginning of the end for this bull market, warns Ralph Nader

    Apparently so, according to consumer advocate and former presidential candidate Ralph Nader, who issued a stark warning this week, not only on the electric-car maker's pricey stock, but on the stock market as a whole. “Deep in debt, selling less than 400,000 vehicles last year and challenged by several competing electric car models in 2020, Tesla's stock valuation stunningly exceeds VW which sold over 10 million vehicles last year,” Nader added in a follow-up tweet. Of course, his stance didn't sit well with Tesla fans.

  • Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 15%
    Business
    TipRanks

    Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 15%

    The stock analysts at Goldman Sachs have been busy. All of this is bread and butter for TipRanks, a platform that makes financial recommendations accountable, and expensive institutional datasets available, to all investors. Three tech stocks that usually fly under the radar – but Goldman sees them all with more than 15% upside potential in the coming year.

  • Retirement: What Happens If a Spouse Dies?
    Business
    Investopedia

    Retirement: What Happens If a Spouse Dies?

    This form names the person or people who will receive your IRA and in what proportions. You can amend the form at any time, but whoever is on the form upon your death will receive the funds—even if they are an ex-spouse or a disinherited child. "If you name multiple people as beneficiaries of one retirement plan, they all take required minimum distributions (RMDs) based on the life expectancy of the eldest beneficiary (i.e., the person who has to take out the largest distributions).

  • Mark Cuban: Where the ‘frothy’ market goes from here depends on one thing
    Business
    MarketWatch

    Mark Cuban: Where the ‘frothy’ market goes from here depends on one thing

    “Interest rates were a lot different back then,” he continued. A day earlier, fellow billionaire Paul Tudor Jones, from the sidelines of the World Economic Forum in Davos, said we are currently in the “craziest monetary and fiscal mix in history,” and, at least to him, it's reminiscent of 1999. What happens next in the stock market, he said, depends where interest rates go from here.

  • FICO scores, the 'most important numbers in your financial life,' are about to change
    Business
    USA TODAY

    FICO scores, the 'most important numbers in your financial life,' are about to change

    Americans who fall behind on loan payments, rack up rising debt or take out personal loans to consolidate debt will likely see their credit scores fall under updates planned for the popular FICO scores, according to Fair Isaac Corp., the creator FICO scores. “Most consumers will see less than a 20-point swing in either direction,” David Shellenberger, FICO's vice president, product management, scores, said in a statement on Thursday. About 40 million, he said, will see a sharper shift upward in scores, and 40 million will be hit with a similar-sized drop, Shellenberger said.

  • Dow Jones Futures: Intel, Atlassian Soar On Earnings, Boost 3 Leaderboard Stocks; Broadcom Rises On Apple Deal
    Business
    Investor's Business Daily

    Dow Jones Futures: Intel, Atlassian Soar On Earnings, Boost 3 Leaderboard Stocks; Broadcom Rises On Apple Deal

    Dow Jones futures and S&P 500 futures edged higher Thursday, while Nasdaq futures rose modestly, after the stock market rally showed continued resilience amid an expanding China coronavirus crisis. Chip giant Intel and software maker Atlassian crushed earnings views. Intel stock jumped in extended trade, with AMD stock and Nvidia stock also getting a lift.

  • Surgical Robotics Leader Dives As Sales, Earnings Growth Decelerate
    Business
    Investor's Business Daily

    Surgical Robotics Leader Dives As Sales, Earnings Growth Decelerate

    Surgical robotics giant Intuitive Surgical reported decelerating sales and earnings growth Thursday, leading ISRG stock to slide in after-hours trading. During the fourth quarter, Intuitive Surgical profit jumped nearly 18% to $3.48 a share. Likewise, the surgical robotics company pulled in $1.28 billion in fourth-quarter sales, growing 22% year over year to beat expectations for $1.2 billion.

  • Britain's Prince Charles appears to snub Pence
    World
    Associated Press Videos

    Britain's Prince Charles appears to snub Pence

    Britain's Prince Charles appeared to snub U.S. Vice President Mike Pence on Thursday during his arrival to the World Holocaust Forum event. Jan.

  • Wells Fargo former CEO John Stumpf fined $17.5 million, banned for life from banking
    Business
    American City Business Journals

    Wells Fargo former CEO John Stumpf fined $17.5 million, banned for life from banking

    Wells Fargo former Chairman and CEO John Stumpf has agreed to pay a fine of $17.5 million and accept a lifetime ban from the banking industry in a settlement the Office of the Comptroller of the Currency announced Thursday. Hope Hardison, Wells Fargo's (NYSE: WFC) former chief administrative officer and director of corporate human resources, agreed to pay a fine of $2.25 million and a personal cease and desist order that requires her to refrain from certain conduct in the future. The bank's former Chief Risk Officer Michael Loughlin will pay a fine of $1.25 million and a personal cease and desist order.

  • Qorvo and Skyworks Weigh Bids for Broadcom’s RF Chip Unit
    Business
    Bloomberg

    Qorvo and Skyworks Weigh Bids for Broadcom’s RF Chip Unit

    Semiconductor makers Qorvo Inc. and Skyworks Solutions Inc. are weighing bids for Broadcom Inc.

  • Chipmaker Intel Smashes Fourth-Quarter Targets, Guides Higher
    Business
    Investor's Business Daily

    Chipmaker Intel Smashes Fourth-Quarter Targets, Guides Higher

    Chipmaking giant Intel late Thursday smashed Wall Street's sales and earnings targets for the fourth quarter and gave an upbeat outlook for 2020. The Intel earnings report sent INTC stock surging in extended trading. Analysts expected Intel earnings of $1.24 a share on sales of $19.2 billion, according to Zacks Investment Research.

  • Business
    Barrons.com

    10 Companies Microsoft Could Buy to Boost Its Growing Cloud Business

    It might be time for (MSFT) to go shopping. Piper Sandler analyst Brent Bracelin asserts in a research note Thursday that 2020 could be a defining year for the software giant. He argues that Microsoft (ticker: MSFT) has “a unique opportunity to further elevate its cloud leadership position through share gains and needle-moving M&A.” The company's huge run to a $1 trillion-plus valuation has been driven by the remarkable growth in its Azure cloud business, which is smaller than (AMZN)'s (AMZN) Amazon Web Services but growing faster—and Bracelin thinks the company can press its advantage with a smart deals.

  • Intel enjoys big rebound in cloud, but the future is still hazy
    Business
    MarketWatch

    Intel enjoys big rebound in cloud, but the future is still hazy

    Intel Corp. wrapped up a rocky 2019 by reporting record sales thanks to a big jump in sales of chips for data centers and cloud computing, but that rebound may just be temporary. The chip giant reported Thursday that its quarterly revenue surged past $20 billion for the first time ever at the end of 2019, fueled in part by a 19% jump in data center sales to $7.2 billion in the fourth quarter, a record performance for Intel's (INTC) second largest business. The data center arena has been feast or famine for the entire chip industry, as the sporadic ups and downs of hyperscaler companies and public cloud service providers have created doubts about where the cloud boom is headed.

  • FDA approves local biotech's first rare-cancer drug
    Business
    American City Business Journals

    FDA approves local biotech's first rare-cancer drug

    The FDA has approved the first-ever commercial cancer treatment from Cambridge biotech Epizyme Inc. Just a few years ago, Epizyme had given up on its potential cancer treatment and sold it to a Japanese drug company. On Thursday, the FDA approved the drug, Tazverik, to treat metastatic or locally advanced epitheliod sarcoma, a rare and aggressive form of soft tissue cancer. Tazverik is the first drug specifically designed for the cancer, which is diagnosed in 150 to 200 people each year, according to Epizyme.

  • Business
    TheStreet.com

    7 Low-Risk Investments With High Returns in 2020

    The classic risk-free investment is Treasury securities, but even they carry some degree of price risk from changes in interest rates, though the risk of default is slim to none. To be clear, dividend-paying stocks do carry risk as they are still subject to the same factors that impact the stock market. Investing for dividend yield is about finding those companies that pay higher dividends as a source of yield.

  • What to watch in the markets: Friday, Jan 24
    Business
    Yahoo Finance Video

    What to watch in the markets: Friday, Jan 24

    Yahoo Finance's Myles Udland highlights the day's market action and upcoming earnings to drive headlines.

  • Young trader’s epic Beyond Meat stock misfire: ‘Biggest mistake of my life’
    Business
    MarketWatch

    Young trader’s epic Beyond Meat stock misfire: ‘Biggest mistake of my life’

    For veteran Wall Street types, $12,000 is a rounding error, but for a guy getting his feet wet in the options pits, losing that much will leave a scar. Unfortunately, that's what happened this week to an anonymous trader whom we'll call “Juice,” if the sob story he shared on Reddit is accurate. “I thought I'd give options a try because I was doing pretty well swing trading and it was probably the biggest mistake of my life,” he wrote in a post.

  • A Tale of 3 Healthcare Stocks – 2 to Buy, and 1 to Sell
    Business
    TipRanks

    A Tale of 3 Healthcare Stocks – 2 to Buy, and 1 to Sell

    So when Oppenheimer announced on Wednesday that it's taken a good hard look at the healthcare industry, and come up with two stocks it's confident it can recommend buying -- and one it's pretty sure should be sold -- this is advice investors should give careful consideration. Let's find out what Oppenheimer has to say, beginning with: Regeneron is one of a strange breed in biotech -- a company that actually makes money. years in business, Tarrytown, NY-based Regeneron develops medicines to treat a wide array of illnesses, everything from age-related macular degeneration and diabetic retinopathy (Eylea) to atopic dermatitis (Dupixent) to atherosclerotic cardiovascular disease (Praluent) and l...

  • Business
    MarketWatch

    Broadcom: Deals with Apple could be worth $15 billion

    Broadcom Inc. (avgo) disclosed Thursday afternoon new deals with Apple Inc. (aapl) worth $15 billion, and shares moved higher in extended trading. In a filing with the Securities and Exchange Commission, the chip maker said that it had signed two multiyear statement of work agreements with the iPhone manufacturer for components that will be included in Apple products beginning this month. The two deals are in addition to an agreement to supply RF chips that Broadcom disclosed last summer.

  • I’m 38 with $315,000 saved for retirement, but have $30,000 in debt. Should I lower my 401(k) contributions to get rid of that debt?
    Business
    MarketWatch

    I’m 38 with $315,000 saved for retirement, but have $30,000 in debt. Should I lower my 401(k) contributions to get rid of that debt?

    Dear Catey, I currently have about $315,000 in retirement savings and am 38 years old. I have about $30,000 in consumer debt (this is the only debt we carry, no car payment or mortgage) — about $24,000 of which is an unsecured loan that I'm paying about 10% interest on; the rest is on credit cards that are on a 0% promotional period and that I hopefully pay off before the 0% period expires in October 2020. I'm trying to pay down my debt and continue to save aggressively for retirement…I've made minimal improvements over the past couple of years paying down my debt and continue to play the balance transfer game on credit cards to retain 0% interest rates or other low rate options.

  • These 10 Rules Made Warren Buffett a Billionaire
    Business
    MoneyWise

    These 10 Rules Made Warren Buffett a Billionaire

    Warren Buffett may be worth tens of billions, but he still lives simply, and his strategies for smart investing and amassing wealth aren't too complicated either. Buffett's first key to prosperity has little to do with picking stocks. "Without good communication skills, you won't be able to convince people to follow you even though you see over the mountain and they don't," Buffett once told a Stanford MBA student.

  • Analysts: These 3 “Strong Buy” Penny Stocks Could Gain Over 50%
    Business
    TipRanks

    Analysts: These 3 “Strong Buy” Penny Stocks Could Gain Over 50%

    Using TipRanks' Stock Screener tool, we filtered the results by current share price, analyst consensus and price target upside to track down 3 penny stocks that have amassed enough analyst support to earn a “Strong Buy” consensus rating. Adding to the good news, each pick boasts over 50% upside potential. Let's dive in.

  • Business
    Financial Times

    Intel: feeling chipper 

    Intel has finally regained its position as the world's biggest chipmaker after more than a year in the cold. The more companies opt to rent data storage from cloud services the better Intel's data centre unit performs. The downside is that technology giants tend to expand data centre capacity in fits and starts.

  • Business
    Thomson Reuters StreetEvents

    Edited Transcript of FCEL earnings conference call or presentation 22-Jan-20 3:00pm GMT

    Q4 2019 FuelCell Energy Inc Earnings Call

  • Alibaba, Luckin Coffee, Other China Stocks Pressured As Coronavirus Crisis Deepens
    Business
    Investor's Business Daily

    Alibaba, Luckin Coffee, Other China Stocks Pressured As Coronavirus Crisis Deepens

    China stocks came under pressure again as the coronavirus crisis gripping the country deepened, with several China cities under full or partial lockdowns in an attempt to control its spread. China stocks affected included e-commerce giant Alibaba, hotel chain Huazhu Group, fast food name Yum China, Luckin Coffee, casino firm Melco Resorts and for-profit school stocks TAL Education and New Oriental Education. However, Alibaba stock, New Oriental Education stock and many others rebounded off lows, with piping-hot Luckin Coffee stock erasing losses.